使用动静脉内瘘行维持性血液透析患者接受连续肾脏替代治疗时血管通路选择的研究进展

    Research advances of selecting vascular access for continuous renal replacement therapy in maintenance hemodialysis patients with arteriovenous fistula

    • 摘要: 血管通路是维持性血液透析(maintenance hemodialysis,MHD)患者的生命线。MHD患者常因感染等各种并发症入院。部分患者病情危重、血流动力学不稳定,无法离开病房前往血液透析室接受透析治疗,需接受床旁连续肾脏替代治疗(continuous renal replacement therapy,CRRT)。对于长期使用动静脉内瘘(arteriovenous fistula,AVF)行血液透析的患者,AVF穿刺或放置临时中心静脉导管均可为CRRT提供血管通路。使用AVF可减少中心静脉穿刺相关风险,但可能损伤AVF,甚至造成AVF失功。使用中心静脉临时置管保护了AVF,但增加了中心静脉穿刺的风险。目前在血管通路的选择上仍存争议。本文就MHD患者CRRT治疗时血管通路选择的相关理论依据及循证医学证据进行归纳总结,以期为临床应用和临床研究提供指导和参考。

       

      Abstract: Hemodialysis vascular access is a vital lifeline for maintenance hemodialysis(MHD) patients. They are frequently hospitalized for infection. Some critically ill patients are hemodynamically unstable and can not receive treatment at a hemodialysis center. Therefore bedside continuous renal replacement therapy(CRRT) is required. For those with arteriovenous fistula(AVF), puncturing or temporary central venous catheterization provide vascular access for CRRT. Using AVF lowers the risks associated with central venipuncture. However, it may carry the risk of AVF injury or dysfunction. Using a temporary central venous catheter protects AVF and yet elevates the risk of central venous puncture related complications. Therefore this review summarized the relevant mechanism and the clinical selection of vascular access during CRRT in MHD patients with AVF. It may guide clinical practices and clinical researches.

       

    /

    返回文章
    返回